Epithelioid Fibrous Histiocytoma: A Concise Review.
Anaplastic Lymphoma Kinase
/ genetics
Biomarkers, Tumor
/ analysis
Diagnosis, Differential
Epithelioid Cells
/ chemistry
Gene Fusion
Gene Rearrangement
Genetic Predisposition to Disease
Histiocytoma, Benign Fibrous
/ chemistry
Humans
Phenotype
Predictive Value of Tests
Prognosis
Soft Tissue Neoplasms
/ chemistry
Journal
The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
pubmed:
6
10
2018
medline:
15
4
2020
entrez:
6
10
2018
Statut:
ppublish
Résumé
Epithelioid fibrous histiocytoma (EFH) is a rare lesion believed to arise from dermal microvascular unit fibroblasts and dendritic histiocytes. EFH has long been considered a morphologic variant of benign fibrous histiocytoma (dermatofibroma), with prominent epithelioid cytomorphology that can mimic both vascular and melanocytic neoplasms. The molecular basis for the relationship between EFH and benign fibrous histiocytoma has remained largely unknown, with some authors suggesting that EFH represents an entity that is biologically distinct from benign fibrous histiocytoma. Recent molecular studies have identified the presence of recurrent anaplastic lymphoma kinase (ALK) gene rearrangements, a phenomenon that has not been described in benign fibrous histiocytoma. These new molecular findings highlight the uniqueness of this rare tumor and may prove useful as a diagnostic tool for differentiation from other histologic mimics.
Identifiants
pubmed: 30289773
doi: 10.1097/DAD.0000000000001272
doi:
Substances chimiques
Biomarkers, Tumor
0
ALK protein, human
EC 2.7.10.1
Anaplastic Lymphoma Kinase
EC 2.7.10.1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
879-883Commentaires et corrections
Type : ErratumIn